121 related articles for article (PubMed ID: 32533049)
21. The IRAK-M death domain: a tale of three surfaces.
Gürkan B; Poelman H; Pereverzeva L; Kruijswijk D; de Vos AF; Groenen AG; Nollet EE; Wichapong K; Lutgens E; van der Poll T; Du J; Wiersinga WJ; Nicolaes GAF; van 't Veer C
Front Mol Biosci; 2023; 10():1265455. PubMed ID: 38268724
[TBL] [Abstract][Full Text] [Related]
22. IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.
Shen P; Li Q; Ma J; Tian M; Hong F; Zhai X; Li J; Huang H; Shi C
BMC Microbiol; 2017 Aug; 17(1):185. PubMed ID: 28835201
[TBL] [Abstract][Full Text] [Related]
23. IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production.
Zhou H; Yu M; Fukuda K; Im J; Yao P; Cui W; Bulek K; Zepp J; Wan Y; Kim TW; Yin W; Ma V; Thomas J; Gu J; Wang JA; DiCorleto PE; Fox PL; Qin J; Li X
EMBO J; 2013 Feb; 32(4):583-96. PubMed ID: 23376919
[TBL] [Abstract][Full Text] [Related]
24. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1.
McDermott EP; O'Neill LA
J Biol Chem; 2002 Mar; 277(10):7808-15. PubMed ID: 11744690
[TBL] [Abstract][Full Text] [Related]
25. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
[TBL] [Abstract][Full Text] [Related]
26. Minimal structure of IRAK-1 to induce degradation of TRAF6.
Watanabe S; Zenke K; Sugiura Y; Muroi M
Immunobiology; 2022 Sep; 227(5):152256. PubMed ID: 35926385
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M.
Rothschild DE; Zhang Y; Diao N; Lee CK; Chen K; Caswell CC; Slade DJ; Helm RF; LeRoith T; Li L; Allen IC
EBioMedicine; 2017 Feb; 15():36-47. PubMed ID: 27939424
[TBL] [Abstract][Full Text] [Related]
28. An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy.
Liu PH; Shah RB; Li Y; Arora A; Ung PM; Raman R; Gorbatenko A; Kozono S; Zhou XZ; Brechin V; Barbaro JM; Thompson R; White RM; Aguirre-Ghiso JA; Heymach JV; Lu KP; Silva JM; Panageas KS; Schlessinger A; Maki RG; Skinner HD; de Stanchina E; Sidi S
Nat Cell Biol; 2019 Feb; 21(2):203-213. PubMed ID: 30664786
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M.
Miyata M; Lee JY; Susuki-Miyata S; Wang WY; Xu H; Kai H; Kobayashi KS; Flavell RA; Li JD
Nat Commun; 2015 Jan; 6():6062. PubMed ID: 25585690
[TBL] [Abstract][Full Text] [Related]
30. Novel small molecule XPO1/CRM1 inhibitors induce nuclear accumulation of TP53, phosphorylated MAPK and apoptosis in human melanoma cells.
Yang J; Bill MA; Young GS; La Perle K; Landesman Y; Shacham S; Kauffman M; Senapedis W; Kashyap T; Saint-Martin JR; Kendra K; Lesinski GB
PLoS One; 2014; 9(7):e102983. PubMed ID: 25057921
[TBL] [Abstract][Full Text] [Related]
31. Threonine 66 in the death domain of IRAK-1 is critical for interaction with signaling molecules but is not a target site for autophosphorylation.
Neumann D; Kollewe C; Pich A; Cao P; Resch K; Martin MU
J Leukoc Biol; 2008 Sep; 84(3):807-13. PubMed ID: 18524972
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.
Li Z; Younger K; Gartenhaus R; Joseph AM; Hu F; Baer MR; Brown P; Davila E
J Clin Invest; 2015 Mar; 125(3):1081-97. PubMed ID: 25642772
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of MicroRNA-708 Targeting BAMBI in Cell Proliferation, Migration, and Apoptosis in Mice With Melanoma via the Wnt and TGF-β Signaling Pathways.
Lu HJ; Yan J; Jin PY; Zheng GH; Zhang HL; Bai M; Wu DM; Lu J; Zheng YL
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756784. PubMed ID: 29466930
[TBL] [Abstract][Full Text] [Related]
34. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.
Williams KL; Lich JD; Duncan JA; Reed W; Rallabhandi P; Moore C; Kurtz S; Coffield VM; Accavitti-Loper MA; Su L; Vogel SN; Braunstein M; Ting JP
J Biol Chem; 2005 Dec; 280(48):39914-24. PubMed ID: 16203735
[TBL] [Abstract][Full Text] [Related]
35. Regulation of IRAK-1 activation by its C-terminal domain.
Nguyen T; De Nardo D; Masendycz P; Hamilton JA; Scholz GM
Cell Signal; 2009 May; 21(5):719-26. PubMed ID: 19166926
[TBL] [Abstract][Full Text] [Related]
36. 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.
Liu L; Nam S; Tian Y; Yang F; Wu J; Wang Y; Scuto A; Polychronopoulos P; Magiatis P; Skaltsounis L; Jove R
Cancer Res; 2011 Jun; 71(11):3972-9. PubMed ID: 21610112
[TBL] [Abstract][Full Text] [Related]
37. A novel mouse model of conditional IRAK-M deficiency in myeloid cells: application in lung Pseudomonas aeruginosa infection.
Jiang D; Matsuda J; Berman R; Schaefer N; Stevenson C; Gross J; Zhang B; Sanchez A; Li L; Chu HW
Innate Immun; 2017 Feb; 23(2):206-215. PubMed ID: 28120642
[TBL] [Abstract][Full Text] [Related]
38. IRAK-M expression limits dendritic cell activation and proinflammatory cytokine production in response to Helicobacter pylori.
Shiu J; Czinn SJ; Kobayashi KS; Sun Y; Blanchard TG
PLoS One; 2013; 8(6):e66914. PubMed ID: 23776703
[TBL] [Abstract][Full Text] [Related]
39. IRAK-M is a negative regulator of Toll-like receptor signaling.
Kobayashi K; Hernandez LD; Galán JE; Janeway CA; Medzhitov R; Flavell RA
Cell; 2002 Jul; 110(2):191-202. PubMed ID: 12150927
[TBL] [Abstract][Full Text] [Related]
40. Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway.
Benito-Jardón L; Díaz-Martínez M; Arellano-Sánchez N; Vaquero-Morales P; Esparís-Ogando A; Teixidó J
Cancer Res; 2019 May; 79(9):2244-2256. PubMed ID: 30833419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
